Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives having the general formula
1
wherein R, R
1
, R
2
, R
3
, R
4
and R
5
, are as defined herein, or a non-toxic pharmaceutically acceptable salt, solvate or prodrug thereof. The atropisomers can modulate the large conductance calcium-activated K
+
channels and are useful in the treatment of disorders which are responsive to the opening of the potassium channels. In addition, the atropisomers can be stable, i.e., do not interconvert, for periods of up to one month, or more.
具有一般式1的3-取代-4-芳基
喹啉-2-酮衍
生物的旋光异构体,其中R、R1、R2、R3、R4和R5如此处所定义,或其无毒药学上可接受的盐、溶剂化合物或前药。这些旋光异构体可以调节大电导
钙激活K+通道,并可用于治疗对开放
钾通道有反应的疾病。此外,这些旋光异构体可以稳定,即在长达一个月或更长时间内不会相互转化。